QI Analysis & Glide Path
This analysis is designed to improve the likelihood that we benefit from the 5-weighted QI measures.
Understanding what's on this page using example data:
Projected QI Ratings: Both Part C QI and Part D QI are projected to have a rating of 5, on a scale of 1 to 5, where 5 represents the highest QI Rating possible.
Measure Set: A list of specific quality measures is shown, indicating whether each measure is "Behind" or "On Track to Achieve QI Significant Improvement." Most measures are marked as "Behind," implying that the plan needs to make improvements to meet its QI targets.
Bar Chart (Breast Cancer Screening): This chart illustrates the historical monthly performance for the 'Breast Cancer Screening' measure. It compares actual performance across three years (2021, 2022, 2023) against a glide path – a projected target line based on the 2022 trend. The bar chart shows that while performance has been improving year over year, it is still behind the glide path needed to achieve significant improvement.
Key Metrics for Breast Cancer Screening:
Planned Target: The target score for this measure is 77.0.
Stars 2024: The actual score achieved in 2024 was 76.8.
Projected Year-End: The projected score by the end of the current year is 79.0.
Sig. Improvement: The score needed for significant improvement is 77.2.
The screen is designed to help plan administrators understand the current status of their quality measures, how they have been trending over time, and what targets need to be met for significant quality improvement. This kind of analysis is critical for ensuring that the health plan meets CMS Star Ratings criteria and for implementing timely interventions where needed to improve the plan's overall performance.
Last updated